Royce & Associates’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-29,205
| Closed | -$199K | – | 881 |
|
|
2024
Q1 | $199K | Sell |
29,205
-23,860
| -45% | -$162K | ﹤0.01% | 834 |
|
|
2023
Q4 | $360K | Buy |
+53,065
| New | +$360K | ﹤0.01% | 813 |
|
|
2022
Q1 | – | Sell |
-17,700
| Closed | -$199K | – | 966 |
|
|
2021
Q4 | $199K | Sell |
17,700
-596,807
| -97% | -$6.71M | ﹤0.01% | 946 |
|
|
2021
Q3 | $10.9M | Buy |
614,507
+523,607
| +576% | +$9.29M | 0.08% | 385 |
|
|
2021
Q2 | $1.74M | Buy |
90,900
+35,800
| +65% | +$683K | 0.01% | 780 |
|
|
2021
Q1 | $1.17M | Buy |
+55,100
| New | +$1.17M | 0.01% | 836 |
|